Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases

Details for Australian Patent Application No. 2003242591 (hide)

Owner Novartis AG

Inventors Vaupel, Andrea; Boss, Eugen; Manley, Paul William; Floersheimer, Andreas; Bold, Guido; Guagnano, Vito; Furet, Pascal

Agent Davies Collison Cave

Pub. Number AU-B-2003242591

PCT Number PCT/EP03/05634

PCT Pub. Number WO2003/099771

Priority 0212413.9 29.05.02 GB; 0305684.3 12.03.03 GB; 0309219.4 23.04.03 GB

Filing date 28 May 2003

Wipo publication date 12 December 2003

Acceptance publication date 26 July 2007

International Classifications

A61K 31/33 (2006.01) - Heterocyclic compounds

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/4439 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5377 (2006.01)

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 15/08 (2006.01) Drugs for genital or sexual disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 0212413.9 29.05.02 GB; 0305684.3 12.03.03 GB; 0309219.4 23.04.03 GB

5 February 2004 Application Open to Public Inspection

  Published as AU-B-2003242591

26 July 2007 Application Accepted

  Published as AU-B-2003242591

22 November 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003242592-AMIDE DERIVATIVES AS INHIBITORS OF THE ENZYMATIC ACTIVITY OF RENIN

2003242590-TWO CRYSTALLINE HYDRATE FORMS OF AMLODIPINE BENZENESULFONATE OF HIGH PURITY, PROCESSES FOR THEIR PREPARATION AND USE